Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.